Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer

Oncology

Volumn 55, Issue 4, 1998, Pages 307-319

  Hiraga, Yuko ^a   Tanaka, Shinji ^a   Haruma, Ken ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a   Shimamoto, Fumio ^b   Kohno, Nobuoki ^c  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Metastasis; MUC1; Prognosis; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY; MUCIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANTIGENS; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MUCINS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL ANALYSIS;

EID: 0031813126     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011868     Document Type: Article

References (30)

1. Irimura T, McIsaac AM, Carlson DA, Yagita M, Grimm EA, Menter DG, Ota DM, Cleary KR: Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells. Cancer Res 1990;50:3331-3338.
2. Dahiya R, Kwak K-S, Byrd JC, Ho S, Yoon W-H, Kim YS: Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 1993;53:1437-1443.
3. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani E-N, Wilson D: Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990;265:15286-15293.
4. Wreschner DH, Hareuveni M, Tsarfaty I, Smorodinsky N, Horev J, Zaretsky J, Kotkes P, Weiss M, Lathe R, Dion A, Keydar I: Human epithelial tumor antigen cDNA sequences: Differential splicing may generate multiple protein forms. Eur J Biochem 1990;189:463-473.
5. Gendler SJ, Spicer AP, Lalani E-N, Duhig T, Peat N, Burchell J, Pemberton L, Boshell M, Taylor-Papadimitriou J: Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis 1991;144:S42-47.
6. Niv Y, Byrd JC, Ho SB, Dahiya R, Kim YS: Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer 1992;50:147-152.
7. Ligtenberg MJL, Buijs F, Vos HL, Hilkens J: Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992;52:2318-2324.
8. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T: MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106: 353-361.
9. Peat N, Gendler SJ, Lalani E-N, Duhing T, Taylor-Papadimitriou J: Tissue-specific expression of a human polymorphic epithelial mucin (MUC-1) in transgenic mice. Cancer Res 1992;52:1954-1960.
10. x expression. Cancer Res 1993;53:4082-4088.
11. Irimura T, Carlson DA, Price J, Yamori T, Giavazzi R, Ota DM, Cleary KR: Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues. Cancer Res 1988;48:2353-2360.
12. Yuan M: Mucin core peptide expression in malignant and non-malignant colorectal tissues (in Chinese, English abstract). Chung Hua Chung Liu Tsa Chih 1992;14:267-269.
13. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K: KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-642.
14. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-216.
15. Kohno N, Inoue Y, Hamada H, Fujioka S, Fujino S, Yokoyama A, Hiwada K, Ueda N, Akiyama M: Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer 1994(suppl 8):81-83.
16. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M: Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 1992;102:117-122.
17. Stahel RA, Gilks WR, Lehmann H-P, Schenker T: Third International Workshop on Lung Tumor and Differentiation Antigens: Overview of the results of the central data analysis. Int J Cancer 1994(suppl 8):6-26.
18. Celis JE, Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin/proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-3266.
19. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
20. Zuber M, Tan EM, Ryoji M: Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989;9:57-66.
21. Jaskulski D, de Riel JK, Mercer WE, Calabretta B, Baserga R: Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 1988;240:1544-1546.
22. Tanaka S, Haruma K, Tatsuta S, Hiraga Y, Teixeira CR, Shimamoto F, Yoshihara M, Sumii K, Kajiyama G: Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 1995;52:134-139.
23. Tanaka S, Haruma K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F: Endoscopie treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995; 30:710-717.
24. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G: Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 1994;73:575-579.
25. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F: The clinical significance of the histologic subclassification of colorectal carcinoma. Oncology 1993;50:495-499.
26. Jass JR, Sobin LH: Histological typing of intestinal tumours; in WHO (ed): International Histological Classification of Tumours, ed 2. Berlin, Springer, 1989, pp 29-40.
27. Japanese Research Society for Cancer of Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, ed 5. Tokyo, Kanahara, 1994.
28. Makiguchi Y, Hinoda Y, Imai K: Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth. Jpn J Cancer Res 1996;87: 505-511.
29. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J: Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-265.
30. Yamamoto M, Bhavanandan VP, Nakamori S, Irimura T: A novel monoclonal antibody specific for sialylated MUC1 mucin. Jpn J Cancer Res 1996;87:488-496.